Inflammatory biomarkers after an exercise intervention in childhood acute lymphoblastic leukemia survivors.
Tuomas Lähteenmäki Taalas, Liisa Järvelä, Harri Niinikoski...
https://pubmed.ncbi.nlm.nih.gov/36467791/Actively Recruiting
Led by University of Utah · Updated on 2026-02-05
40
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are exploring a new telerehabilitation program for patients receiving CAR-T cell immunotherapy for blood cancers like lymphoma and myeloma. This approach aims to improve quality of life, physical function, and symptoms by offering personalized exercise, nutrition, behavioral counseling, social support, and education. The study focuses on the safety and feasibility of this model using an online platform that monitors patients health and progress in real-time with the help of artificial intelligence. Participants will start with a four-week personalized prehabilitation program before starting CAR-T therapy. During treatment, they will use an interactive app for cancer self-care education and early mobilization while undergoing chemotherapy, CAR-T infusion, and hospital monitoring. After discharge, they will follow a 12-week home-based multimodal telerehabilitation plan that includes exercises, nutrition guidance, and social support through group telecounseling, all monitored via web-based tools and wearable devices like pulse oximeters and fitness trackers. Throughout the study, patients will be assessed for usability and adherence to the program, along with measures of physical fitness, quality of life, symptoms, and satisfaction with care. Assessments include walking tests, physical performance batteries, questionnaires on fatigue and exercise motivation, and cancer-related quality of life surveys. The study lasts up to 12 weeks after CAR-T treatment completion, with ongoing monitoring of exercise exertion and patient-reported outcomes to evaluate the programs impact and feasibility.
CONDITIONS
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
A
Aileen Gabriel
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Utah
Lead Sponsor
United States Department of Defense
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Investigational Digital Telerehabilitation Program | Current Rehabilitation Guidelines for CAR-T Therapy |
|---|---|---|
| What it is | A home-based digital telerehabilitation program using the HAT platform, which provides personalized exercise and diet plans, daily symptom monitoring, and remote communication with the healthcare team. Participants use a tablet or VR headset, a pulse oximeter, and a Fitbit for guided rehabilitation activities before and after CAR-T cell infusion. | A supervised, guideline-based rehabilitation program for people with hematologic malignancies, including individually tailored aerobic and resistance exercise and physical activity counseling, overseen by a qualified rehabilitation provider during and after CAR-T cell therapy. |
| Role in trial | Tested as an intervention to support recovery, physical function, and feasibility for patients scheduled for CAR-T cell therapy. | Recommended as standard supportive care to reduce disability, maintain function, and improve quality of life for people receiving intensive hematologic cancer therapies. |
| Primary use | Used to provide remote, structured rehabilitation support before and after CAR-T cell infusion, including personalized exercises and ongoing progress tracking. | Used to provide in-person or hybrid supervised exercise and rehabilitation throughout cancer treatment to improve functional status, reduce treatment side effects, and prevent disability. |
| How it is given or performed | Patients use a provided touchscreen tablet or VR headset at home, follow individualized exercise and diet plans, and upload daily health data, including pulse oximetry and activity tracking, to a central care team for review and support. Monitoring and supervision are all conducted remotely. | Typically delivered face-to-face in outpatient or inpatient settings, supervised by a physical therapist or rehabilitation specialist. Sessions include personalized aerobic and resistance exercise plans, education, and regular progress assessments. |
| Evidence status | Ongoing study; feasibility, usability, and adherence outcomes are being collected. No published outcome data are available for this intervention in this population yet. | Supported by published guidelines and multiple systematic reviews. Exercise and rehabilitation during and after treatment can improve physical function, reduce fatigue, and support quality of life in patients with hematologic malignancies. |
| Important limitations | Effectiveness for improving function, quality of life, or other patient outcomes in CAR-T therapy recipients is not yet established. The program requires access to technology, basic digital literacy, and may not provide the same hands-on supervision as in-person care. | May be limited by local resource availability, participants' physical status, and interruptions during periods of intensive treatment. In-person rehabilitation may not be feasible for all patients due to immunosuppression or access barriers. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants undergo a four-week multimodal prehabilitation involving individualized exercise, nutrition plans, and preparation before starting CAR-T therapy.
Initial baseline visit with ongoing remote monitoring
Duration - Up to 4 weeks depending on treatment regimen
Participants use an interactive app to support cancer self-care education, early mobilization, and symptom monitoring during chemotherapy, CAR-T infusion, in-hospital toxicity monitoring, and recovery.
Continuous remote monitoring during hospital stay and treatment
Duration - 12 weeks
After hospital discharge, participants engage in a 12-week home-based multimodal telerehabilitation program including personalized exercise, nutrition, behavioral counseling, social support, and interactive education via telemedicine.
Weekly remote sessions with group telecounseling and ongoing monitoring
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Tuomas Lähteenmäki Taalas, Liisa Järvelä, Harri Niinikoski...
https://pubmed.ncbi.nlm.nih.gov/36467791/Laura J Damschroder, Caitlin M Reardon, Marilla A Opra Widerquist...
https://pubmed.ncbi.nlm.nih.gov/36309746/Fabio Efficace, Laura Cannella, Francesco Sparano...
https://pubmed.ncbi.nlm.nih.gov/36504547/Yinning Guo, Lingyu Ding, Xueyi Miao...
https://pubmed.ncbi.nlm.nih.gov/36534300/Hannah K Wilson, Caroline Wieler, Darci L Bell...
https://pubmed.ncbi.nlm.nih.gov/36930404/Mackenzi Pergolotti, Allison M Deal, Jessica Lavery...
https://pubmed.ncbi.nlm.nih.gov/25614296/Joseph Finkelstein, In cheol Jeong
https://pubmed.ncbi.nlm.nih.gov/24111433/N K Aaronson, S Ahmedzai, B Bergman...
https://pubmed.ncbi.nlm.nih.gov/8433390/Jennifer M Jones, Karin Olson, Pamela Catton...
https://pubmed.ncbi.nlm.nih.gov/25876557/M Alexis Kirk, Caitlin Kelley, Nicholas Yankey...
https://pubmed.ncbi.nlm.nih.gov/27189233/University of Utah
Lead Sponsor
United States Department of Defense
Collaborating Sponsor